
XORTX Therapeutics Raises $1.1 Million in Registered Direct Offering

I'm PortAI, I can summarize articles.
XORTX Therapeutics Inc. has successfully closed a registered direct offering, raising approximately $1.1 million. The offering included 1,750,000 common shares and pre-funded warrants priced at $0.63 per share. The company plans to utilize the net proceeds for working capital and general corporate purposes. D. Boral Capital LLC served as the placement agent for the offering.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

